BWX Technologies, Inc. (NYSE:BWXT) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Analyst consensus: 13 brokerages rate BWXT an average of "Moderate Buy" (4 holds, 6 buys, 3 strong buys) with a 12‑month average price target of $200.45.
• Strong quarterly results and guidance: BWXT beat estimates with $1.08 EPS vs. $0.91 expected and $885.8M revenue (up 18.7% YoY), and set FY2026 guidance of $4.55–$4.70 EPS.
• Dividend hike and insider selling: the company raised its quarterly dividend to $0.27 (annualized $1.08, ~0.6% yield), while insiders have sold shares recently (CEO sold 10,000 shares; insiders sold ~13,327 shares worth $2.73M over three months).

Shares of BWX Technologies, Inc. (NYSE:BWXT - Get Free Report) have received an average rating of "Moderate Buy" from the thirteen brokerages that are covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold rating, six have assigned a buy rating and three have assigned a strong buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $200.45.

Several brokerages have recently commented on BWXT. Wall Street Zen cut shares of BWX Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, February 28th. Truist Financial set a $205.00 price objective on BWX Technologies in a research note on Friday, January 9th. Zacks Research raised BWX Technologies from a "hold" rating to a "strong-buy" rating in a report on Wednesday, January 21st. Weiss Ratings upgraded BWX Technologies from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, February 25th. Finally, BTIG Research boosted their price target on BWX Technologies from $225.00 to $235.00 and gave the company a "buy" rating in a report on Thursday, February 26th.

BWX Technologies Stock Down 2.3%

Shares of NYSE:BWXT opened at $195.86 on Wednesday. The firm has a market cap of $17.91 billion, a PE ratio of 54.86, a price-to-earnings-growth ratio of 3.27 and a beta of 0.83. The company has a fifty day simple moving average of $201.97 and a 200 day simple moving average of $189.26. The company has a current ratio of 2.32, a quick ratio of 2.25 and a debt-to-equity ratio of 1.64. BWX Technologies has a 12-month low of $84.21 and a 12-month high of $220.57.

BWX Technologies (NYSE:BWXT - Get Free Report) last posted its quarterly earnings data on Monday, February 23rd. The technology company reported $1.08 EPS for the quarter, beating analysts' consensus estimates of $0.91 by $0.17. The firm had revenue of $885.84 million for the quarter, compared to the consensus estimate of $837.47 million. BWX Technologies had a net margin of 10.28% and a return on equity of 30.94%. The firm's revenue was up 18.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.92 EPS. BWX Technologies has set its FY 2026 guidance at 4.550-4.700 EPS. On average, equities research analysts anticipate that BWX Technologies will post 3.23 EPS for the current fiscal year.

BWX Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 27th. Shareholders of record on Wednesday, March 11th will be paid a dividend of $0.27 per share. The ex-dividend date is Wednesday, March 11th. This is a positive change from BWX Technologies's previous quarterly dividend of $0.25. This represents a $1.08 annualized dividend and a yield of 0.6%. BWX Technologies's payout ratio is presently 28.01%.

Insiders Place Their Bets

In related news, CEO Rex D. Geveden sold 10,000 shares of the business's stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $203.26, for a total transaction of $2,032,600.00. Following the completion of the sale, the chief executive officer owned 177,594 shares of the company's stock, valued at $36,097,756.44. This represents a 5.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Kevin James Gorman sold 1,344 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $214.71, for a total transaction of $288,570.24. Following the sale, the chief accounting officer owned 114 shares in the company, valued at approximately $24,476.94. This trade represents a 92.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 13,327 shares of company stock valued at $2,734,844. Company insiders own 0.47% of the company's stock.

Hedge Funds Weigh In On BWX Technologies

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Aventura Private Wealth LLC acquired a new stake in shares of BWX Technologies during the 4th quarter worth approximately $29,000. WFA of San Diego LLC acquired a new position in BWX Technologies during the 2nd quarter valued at approximately $29,000. Global Trust Asset Management LLC acquired a new position in BWX Technologies during the 3rd quarter valued at approximately $32,000. Strategic Advocates LLC bought a new position in BWX Technologies during the 3rd quarter worth $32,000. Finally, MV Capital Management Inc. bought a new position in BWX Technologies during the 4th quarter worth $32,000. 94.39% of the stock is currently owned by institutional investors and hedge funds.

BWX Technologies Company Profile

BWX Technologies, Inc NYSE: BWXT is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company's core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.